CSIMarket
Enanta Pharmaceuticals Inc  (ENTA)
Other Ticker:  
 
 

Enanta Pharmaceuticals Inc's Yearly Net Income Growth 5 Years

 

Select the Comparisons : Select the Ratio:



ENTA Annual Net Income Growth

2023
2022
2021
2020
2019
Y / Y Annual Net Income Change - - - - -35.54 %
Annual Net Income (in millions $) $-133.82 $-121.76 $-79.00 $-36.17 $46.38


Annual Net Income Growth Comment
Enanta Pharmaceuticals Inc realized net loss.

Enanta Pharmaceuticals Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Net Income within Healthcare SectorY/Y Net Income Growth %2023 Annual Net Income
Merck and Co Inc -97.49 %$ 365.000  millions
Biontech Se -90.14 %$ 1,041.936  millions
Biogen Inc -60.78 %$ 1,161.500  millions
Viatris Inc -97.37 %$ 54.700  millions
Hologic Inc -64.98 %$ 456.000  millions
Agilent Technologies inc -1.12 %$ 1,240.000  millions
Quest Diagnostics Inc -10.54 %$ 908.000  millions
Fresenius Medical Care Ag -18.10 %$ 820.353  millions
Tenet Healthcare Corp  30.97 %$ 1,311.000  millions
Organon and Co   11.56 %$ 1,023.000  millions
Mettler toledo International Inc -9.60 %$ 788.778  millions
Davita Inc   22.43 %$ 956.978  millions
Resmed Inc   15.15 %$ 897.556  millions
United Therapeutics Corporation  35.40 %$ 984.800  millions
Avantor Inc -53.23 %$ 321.100  millions
Idexx Laboratories Inc  24.44 %$ 845.042  millions
West Pharmaceutical Services Inc   1.28 %$ 593.400  millions
Revvity Inc   21.77 %$ 693.094  millions
Henry Schein Inc -22.97 %$ 436.000  millions
Vir Biotechnology Inc